[Antiviral immunodeficiency: EBV, CMV, adenovirus]

Area of Science:

• Immunology
• Transplantation Medicine
• Infectious Diseases

Context:

• Bone marrow transplantation (BMT) recipients experience profound immunodeficiency, increasing susceptibility to opportunistic infections.
• Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus are major viral pathogens causing significant morbidity and mortality post-BMT.
• Impaired T cell immunity, including CD4+ and CD8+ T cell dysfunction, is a primary driver of this heightened vulnerability.

Purpose:

• To investigate the kinetics of immunological reconstitution following BMT.
• To elucidate the role of T cell immunodeficiency in post-transplant viral infections.
• To explore strategies for enhancing antimicrobial defenses post-BMT.

Summary:

• Viral infections pose a significant threat to bone marrow transplant recipients due to prolonged cellular and humoral immunodeficiency.
• Recovery of virus-specific CD8+ T cell responses is delayed, occurring in a minority of patients by day 30-40 post-BMT.
• While T cell recovery is more robust in HLA-identical BMT recipients by day 90, partially incompatible recipients show limited reconstitution, highlighting the need for immune enhancement strategies.

Impact:

• Findings underscore the critical need for strategies to accelerate immune reconstitution or preserve T cell-mediated immunity post-BMT.
• Potential interventions include the add-back of unmanipulated or virus-specific T cells to bolster anti-viral defenses.
• Improved immune recovery could reduce the incidence of life-threatening viral infections and improve long-term outcomes for BMT patients.